SUSAN JACKSON: Open Payments
NPI 1699889949 · UTICA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,091 in 43 payments from 9 companies in 2025. Trend: 2023 $889 · 2024 $728 · 2025 $1,091
Food & beverage: $1,091
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $301 |
| AstraZeneca Pharmaceuticals LP | 7 | $200 |
| Phathom Pharmaceuticals, Inc. | 11 | $166 |
| GlaxoSmithKline, LLC. | 3 | $145 |
| Verona Pharma, Inc. | 1 | $123 |
| ABBVIE INC. | 4 | $71 |
| Grifols USA, LLC | 2 | $49 |
| Janssen Biotech, Inc. | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
Products named: Ozempic, BREZTRI, VOQUEZNA, Ohtuvayre, NUCALA, VRAYLAR, Prolastin-C Liquid, TRELEGY ELLIPTA.
Industry payments across NY — which companies pay providers there.
